Stock Traders Buy High Volume of Call Options on Alignment Healthcare (NASDAQ:ALHC)

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) was the target of some unusual options trading on Monday. Stock traders acquired 5,030 call options on the stock. This is an increase of 392% compared to the average volume of 1,023 call options.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on ALHC shares. UBS Group raised their price target on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. Robert W. Baird raised their target price on shares of Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a report on Tuesday, April 15th. Stephens raised shares of Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, Stifel Nicolaus raised their price target on Alignment Healthcare from $18.00 to $23.00 and gave the stock a "buy" rating in a research note on Tuesday, April 8th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Alignment Healthcare has a consensus rating of "Moderate Buy" and an average target price of $17.17.

Insiders Place Their Bets

In other Alignment Healthcare news, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $15.28, for a total transaction of $259,760,000.00. Following the completion of the sale, the director directly owned 44,302,175 shares in the company, valued at $676,937,234. The trade was a 27.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Andreas P. Wagner sold 19,399 shares of the firm's stock in a transaction that occurred on Wednesday, June 11th. The stock was sold at an average price of $15.26, for a total value of $296,028.74. Following the transaction, the insider owned 204,075 shares in the company, valued at approximately $3,114,184.50. The trade was a 8.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 17,795,262 shares of company stock valued at $272,980,496 over the last ninety days. 7.00% of the stock is owned by insiders.

Institutional Trading of Alignment Healthcare

A number of large investors have recently made changes to their positions in ALHC. Amalgamated Bank raised its holdings in Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after purchasing an additional 616 shares in the last quarter. Ballentine Partners LLC increased its position in Alignment Healthcare by 8.6% during the 1st quarter. Ballentine Partners LLC now owns 11,674 shares of the company's stock worth $217,000 after purchasing an additional 924 shares in the last quarter. MCF Advisors LLC boosted its position in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the period. Cresset Asset Management LLC raised its holdings in shares of Alignment Healthcare by 0.6% during the 1st quarter. Cresset Asset Management LLC now owns 287,565 shares of the company's stock valued at $5,354,000 after buying an additional 1,797 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Alignment Healthcare by 3.9% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 56,963 shares of the company's stock worth $641,000 after purchasing an additional 2,154 shares in the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Price Performance

ALHC stock traded down $0.52 during trading on Thursday, hitting $13.38. The stock had a trading volume of 2,611,439 shares, compared to its average volume of 2,226,025. The stock has a market capitalization of $2.65 billion, a P/E ratio of -27.88 and a beta of 1.16. Alignment Healthcare has a twelve month low of $7.92 and a twelve month high of $21.06. The company's 50-day moving average price is $14.77 and its two-hundred day moving average price is $15.19. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.69 and a quick ratio of 1.69.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.07. The business had revenue of $926.93 million for the quarter, compared to analysts' expectations of $889.83 million. Alignment Healthcare had a negative net margin of 3.02% and a negative return on equity of 80.49%. The business's quarterly revenue was up 47.5% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.25) earnings per share. As a group, research analysts predict that Alignment Healthcare will post -0.69 EPS for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.